Compare ARBE & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARBE | BTMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1M | 65.8M |
| IPO Year | N/A | 2021 |
| Metric | ARBE | BTMD |
|---|---|---|
| Price | $0.68 | $2.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $2.38 | ★ $2.83 |
| AVG Volume (30 Days) | ★ 1.8M | 237.6K |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | $363.94 | $2.03 |
| Revenue Next Year | $286.43 | $6.58 |
| P/E Ratio | ★ N/A | $38.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $1.27 |
| 52 Week High | $2.88 | $4.75 |
| Indicator | ARBE | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 51.40 |
| Support Level | $0.65 | $1.99 |
| Resistance Level | $0.90 | $2.44 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 6.52 | 35.97 |
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.